Clinical study to evaluate efficacy and safety of Dapoxetine Hydrochloride Tablet in treatment of Premature Ejaculation.

Trial Profile

Clinical study to evaluate efficacy and safety of Dapoxetine Hydrochloride Tablet in treatment of Premature Ejaculation.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Dapoxetine (Primary)
  • Indications Premature ejaculation
  • Focus Therapeutic Use
  • Sponsors Emcure Pharmaceuticals
  • Most Recent Events

    • 08 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
    • 13 Jul 2010 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
    • 26 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top